GlaxoSmithKline to pay $3 billion for health fraud
The Glaxo SmithKline logo hangs at the company's head office April 30, 2003 in London.
Photographer: Warren Little/Getty Images
Posted: 07/02/2012
WASHINGTON - The Justice Department says GlaxoSmithKline will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to report important safety data about a diabetes drug to the Food and Drug Administration.
Government officials say it's the largest health care fraud settlement in U.S. history.
Prosecutors say GSK encouraged use of Paxil for children although it was not approved for anyone under 18. The company also promoted Wellbutrin for uses besides major depressive disorder, its only approved use. They say that between 2001 and 2007 GSK failed to report on two studies of the cardiovascular safety of Avandia, a diabetes drug.
Of the penalties, $1 billion covers criminal fines and forfeitures and $2 billion is for civil settlements with the federal and state governments.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
PRINT
National Headlines
-
Mayors push to limit food stamps for pop
The mayors of New York, Los Angeles, Chicago and 15 other cities are reviving a push against letting food stamps be used to buy soda and other sugary drinks.
-
Serena Williams comments on Steubenville
Serena Williams says in an interview with Rolling Stone magazine that, while not blaming the victim in the Steubenville rape case, "she shouldn't have put herself in that position."
-
Tornado touches down near Denver airport
-
Man mauled after feeding bear BBQ
-
Flasher exposes himself at Target
-
Fox gets head stuck in glass jar
-
Chrysler to formally reject Jeep recall
- Trending now on newsnet5
